A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis

American Heart Journal

Volumn 166, Issue 3, 2013, Pages

  Habara, Seiji ^a   Iwabuchi, Masashi ^b   Inoue, Naoto ^c   Nakamura, Shigeru ^d   Asano, Ryuta ^e   Nanto, Shinsuke ^f   Hayashi, Yasuhiko ^g   Shiode, Nobuo ^g   Saito, Shigeru ^h   Ikari, Yuji ⁱ   Kimura, Takeshi ^j   Hosokawa, Joji ^k   Nakamura, Masato ^l   Kotani, Jun Ichi ^m   Kozuma, Ken ⁿ   Mitsudo, Kazuaki ^a  

^a KURASHIKI CENTRAL HOSPITAL   (Japan)

^b KOKURA MEMORIAL HOSPITAL   (Japan)

^c SENDAI KOUSEI HOSPITAL   (Japan)

^d KYOTO KATSURA HOSPITAL   (Japan)

^e SAKAKIBARA HEART INSTITUTE   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g TSUCHIYA GENERAL HOSPITAL   (Japan)

^h SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

ⁱ TOKAI UNIVERSITY HOSPITAL   (Japan)

^j KYOTO UNIVERSITY   (Japan)

^k Tokyo Heart Center   (Japan)

^l TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^m NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

ⁿ TEIKYO UNIVERSITY HOSPITAL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PACLITAXEL; RAPAMYCIN; TICLOPIDINE; ZOTAROLIMUS;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON CATHETER; BARE METAL STENT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; IN-STENT RESTENOSIS; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 84883781403     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.07.002     Document Type: Article

References (25)

1. B. Scheller, C. Hehrlein, and W. Bocksch Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 20 2006 2113 2124
2. B. Scheller, C. Hehrlein, and W. Bocksch Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter Clin Res Cardiol 97 10 2008 773 781
3. M. Unverdorben, C. Vallbracht, and B. Cremers Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 23 2009 2986 2994
4. S. Habara, K. Mitsudo, and K. Kadota Effectiveness of Paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis JACC Cardiovasc Interv 4 2 2011 149 154
5. H. Rittger, J. Brachmann, and A.M. Sinha A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study J Am Coll Cardiol 59 15 2012 1377 1382
6. B. Scheller, Y.P. Clever, and B. Kelsch Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter JACC Cardiovasc Interv 5 3 2012 323 330
7. J. Wohrle, M. Zadura, and S. Mobius-Winkler SeQuent Please World Wide Registry: clinical results of SeQuent Please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study J Am Coll Cardiol 60 18 2012 1733 1738
8. R.A. Byrne, F.-J. Neumann, and J. Mehilli Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial Lancet 381 9865 2012 461 467
9. R. Mehran, G. Dangas, and A.S. Abizaid Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 18 1999 1872 1878
10. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 17 2007 2344 2351
11. A. Kastrati, J. Mehilli, and N. von Beckerath Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial JAMA 293 2 2005 165 171
12. R. Albiero, S. Silber, and C. Di Mario Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the Restenosis Cutting Balloon Evaluation Trial (RESCUT) J Am Coll Cardiol 43 6 2004 943 949
13. F. Alfonso, M.J. Perez-Vizcayno, and R. Hernandez A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial J Am Coll Cardiol 47 11 2006 2152 2160
14. E. Iofina, P.K. Haager, and P.W. Radke Sirolimus- and paclitaxel-eluting stents in comparison with balloon angioplasty for treatment of in-stent restenosis Catheter Cardiovasc Interv 64 1 2005 28 34
15. F. Alfonso, J. Zueco, and A. Cequier A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis J Am Coll Cardiol 42 5 2003 796 805
16. C. Whan Lee, S.H. Kim, and J. Suh Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents Catheter Cardiovasc Interv 71 5 2008 594 598
17. D.H. Steinberg, M.A. Gaglia Jr., and T.L. Pinto Slottow Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents Am J Cardiol 103 4 2009 491 495
18. K. Fujii, G.S. Mintz, and Y. Kobayashi Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis Circulation 109 9 2004 1085 1088
19. G. Sianos, S. Hofma, and J.M. Ligthart Stent fracture and restenosis in the drug-eluting stent era Catheter Cardiovasc Interv 61 1 2004 111 116
20. H. Takebayashi, G.S. Mintz, and S.G. Carlier Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation Circulation 110 22 2004 3430 3434
21. J.R. Nebeker, R. Virmani, and C.L. Bennett Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project J Am Coll Cardiol 47 1 2006 175 181
22. R. Virmani, G. Guagliumi, and A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 6 2004 701 705
23. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 1 2006 193 202
24. S. Habara, K. Mitsudo, and T. Goto The impact of lesion length and vessel size on outcomes after sirolimus-eluting stent implantation for in-stent restenosis Heart 94 9 2008 1162 1165
25. G. Nakazawa, F. Otsuka, and M. Nakano The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents J Am Coll Cardiol 57 11 2011 1314 1322